Compass Therapeutics, Inc.

New Filing
CIK: 0001738021·Other·DELAWARE·Filed: Jul 1, 2020
Total Offering

$70,000,000

Amount Sold

$60,482,210

Investors

110

First Sale

Jun 19, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2018
Non-Accredited Investors
No

Related Persons

NameRole
Julie Sunderland
Related Person
Carl L. Gordon
Related Person
THOMAS J SCHUETZ
Related Person
Philip Ferneau
Related Person
Stephen P. Squinto
Related Person
VERED BISKER-LEIB
Related Person

Company

Compass Therapeutics, Inc.

245 FIRST STREET, 3RD FLOOR

CAMBRIDGE, MA, 02142

617-500-8099

SEC Filing

0001802806-20-000004

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Compass Therapeutics, Inc. Form D Filing — $70,000,000 | FilingFlow